title: Hepatitis C.
authors.forename: Juliana
authors.initials: J
authors.lastname: Chan
mesh_terms: D000328:Adult; D017677:Age Distribution; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D003140:Communicable Disease Control / Q000458:organization & administration*; D019468:Disease Management; D005260:Female; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology* / Q000635:transmission; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000635:transmission; D006575:Heterocyclic Compounds, 3-Ring / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D008103:Liver Cirrhosis / Q000517:prevention & control* / Q000821:virology; D008297:Male; D008875:Middle Aged; D020380:Needs Assessment; D011329:Prisoners / Q000706:statistics & numerical data; D011330:Prisons; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use; D018570:Risk Assessment; D017678:Sex Distribution; D000069616:Simeprevir; D000069474:Sofosbuvir; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use; D017216:Telemedicine / Q000706:statistics & numerical data; D016896:Treatment Outcome; D014481:United States; D014542:Uridine Monophosphate / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D019380:Anti-HIV Agents; D006575:Heterocyclic Compounds, 3-Ring; D013449:Sulfonamides; D012254:Ribavirin; D000069616:Simeprevir; D014542:Uridine Monophosphate; D000069474:Sofosbuvir